Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.61 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | TSHR | P16473 | 5/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | GMNN | O75496 | 1/20 | 0.59 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.59 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.59 |
| ▸ | PPARG | P37231 | 6/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Myristic Acid SCHEMBL9408104 | 1.00 | MAPK1 (0.64) | MAPK1MAPTFFAR4FFAR1ALDH1A1 | |
| SCHEMBL215669 | 1.00 | MAPK1 (0.64) | MAPK1MAPTFFAR4FFAR1ALDH1A1 | |
| SCHEMBL6843599 | 1.00 | MAPK1 (0.64) | MAPK1MAPTFFAR4FFAR1ALDH1A1 | |
| SCHEMBL2154198 | 1.00 | MAPK1 (0.64) | MAPK1MAPTFFAR4FFAR1ALDH1A1 | |
| SCHEMBL23288413 | 1.00 | MAPK1 (0.64) | MAPK1MAPTFFAR4FFAR1ALDH1A1 | |
| SCHEMBL8656695 | 1.00 | MAPK1 (0.64) | MAPK1MAPTFFAR4FFAR1ALDH1A1 | |
| SCHEMBL23860683 | 1.00 | MAPK1 (0.64) | MAPK1MAPTFFAR4FFAR1ALDH1A1 | |
| SCHEMBL23565739 | 1.00 | MAPK1 (0.64) | MAPK1MAPTFFAR4FFAR1ALDH1A1 | |
| SCHEMBL25297686 | 1.00 | MAPK1 (0.64) | MAPK1MAPTFFAR4FFAR1ALDH1A1 | |
| SCHEMBL22589987 | 1.00 | MAPK1 (0.64) | MAPK1MAPTFFAR4FFAR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4734959-A1 | USE OF GLYCERIDES FOR LNP FORMULATIONS | Sanofi Pasteur Inc. (US) | 2026-05-06 | — | — | EP | claimed |
| WO-2025003754-A1 | USE OF GLYCERIDES FOR LNP FORMULATIONS | SANOFI (FR) | 2025-01-02 | — | — | WO | claimed |
| CN-117737146-B | Glyceride type fatty acid hydroxy fatty acid ester and preparation method thereof | 广东省农业科学院蚕业与农产品加工研究所 | 2024-06-18 | — | — | CN | claimed |
| CN-117737146-A | Glyceride type fatty acid hydroxy fatty acid ester and preparation method thereof | 广东省农业科学院蚕业与农产品加工研究所 | 2024-03-22 | — | — | CN | claimed |
| EP-4734959-A1 | USE OF GLYCERIDES FOR LNP FORMULATIONS | Sanofi Pasteur Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| WO-2026089660-A1 | A PLATFORM FOR MIMICKING BIOLOGICAL AIR-INTERFACES | NANYANG TECHNOLOGICAL UNIVERSITY (SG) | 2026-04-30 | — | — | WO | disclosed |
| US-12569439-B2 | Bottom-up assembly of synthetic extracellular vesicles | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-03-10 | — | — | US | disclosed |
| EP-4688725-A1 | FATTY ACID ESTERS OF HYDROXY FATTY ACID | Wilmar International Limited (SG) | 2026-02-11 | — | — | EP | disclosed |
| EP-4637812-A1 | HEPATITIS B COMPOSITIONS | GlaxoSmithKline Biologicals S.A. (BE) | 2025-10-29 | — | — | EP | disclosed |
| EP-4539876-A2 | RECOMBINANT RNA MOLECULES COMPRISING UNTRANSLATED REGIONS OR SEGMENTS ENCODING SPIKE PROTEIN FROM THE OMICRON STRAIN OF SEVERE ACUTE RESPIRATORY CORONAVIRUS-2 | GlaxoSmithKline Biologicals S.A. (BE) | 2025-04-23 | — | — | EP | disclosed |
| US-20250099576-A1 | Recombinant RNA Molecules Comprising Untranslated Regions or Segments Encoding Spike Protein from the Omicron Strain of Severe Acute Respiratory Coronavirus-2 | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2025-03-27 | — | — | US | disclosed |
| CN-119604304-A | Recombinant RNA molecules comprising an untranslated region or a segment encoding spike protein from the Severe acute respiratory coronavirus 2 Omikovia strain | 葛兰素史克生物有限公司 | 2025-03-11 | — | — | CN | disclosed |
| US-20100029622-A1 | MICROEMULSIONS | NEUROSCIENZE PHARMANESS S.C.A.R.L. (IT) | 2010-02-04 | — | — | US | disclosed |
| US-20100028257-A1 | PHARMACEUTICAL COMPOUNDS | NEUROSCIENZE PHARMANESS S.C. A.R.L. (IT) | 2010-02-04 | — | — | US | disclosed |
| EP-2149575-A1 | Diazabicyclic compounds as opioid receptor agonists | Neuroscienze Pharmaness S.C. A R.L. (IT) | 2010-02-03 | — | — | EP | disclosed |
| EP-2149370-A1 | Diazabicyclic compounds and microemulsions thereof | Neuroscienze Pharmaness S.C. A R.L. (IT) | 2010-02-03 | — | — | EP | disclosed |
| US-7491836-B2 | Non-ionic surfactants for poorly soluble molecules | ASTRAZENECA AB (SE) | 2009-02-17 | — | — | US | disclosed |
| US-20060287542-A1 | Non-ionic surfactants for solubilizing poorly solubule molecules | ASTRAZENECA AB (SE) | 2006-12-21 | — | — | US | disclosed |
| EP-1615874-A1 | NEW NON-IONIC SURFACTANTS FOR SOLUBILIZING POORLY SOLUBLE MOLECULES | AstraZeneca AB (SE) | 2006-01-18 | — | — | EP | disclosed |
| WO-2004089869-A1 | NEW NON-IONIC SURFACTANTS FOR SOLUBILIZING POORLY SOLUBLE MOLECULES | ASTRAZENECA AB (SE) | 2004-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100028257-A1 | PHARMACEUTICAL COMPOUNDS | OPRD1, OPRK1, OPRM1 | MAPK1 1372/4885MAPT 3497/4885FFAR4 820/4885 |
| US-20250099576-A1 | Recombinant RNA Molecules Comprising Untranslated Regions or Segments Encoding Spike Protein from the Omicron Strain of Severe Acute Respiratory Coronavirus-2 | RNGTT, RBM25, TMPRSS2 | MAPK1 4108/4885MAPT 2648/4885FFAR4 3910/4885 |
| US-20060287542-A1 | Non-ionic surfactants for solubilizing poorly solubule molecules | LIPA, ELOVL1, FASN | MAPK1 3146/4885MAPT 4810/4885FFAR4 137/4885 |
| US-20100029622-A1 | MICROEMULSIONS | LIPA, APOB, LIPC | MAPK1 4060/4885MAPT 77/4885FFAR4 416/4885 |
| US-12569439-B2 | Bottom-up assembly of synthetic extracellular vesicles | EXOSC10, PLTP, EXOSC9 | MAPK1 1783/4885MAPT 2688/4885FFAR4 256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.